Skip to main content

Table 3 Assessment of TEG at different time points

From: Does subcutaneous administration of recombinant human erythropoietin increase thrombotic events in total hip arthroplasty? A prospective thrombelastography analysis

Indexes

Time points

rHu-EPO group (n = 74)

Control group (n = 78)

P value

R(min)

Pre-op

POD1

POD7

5.95 ± 1.71

5.73 ± 2.04

5.49 ± 1.39

5.98 ± 1.37

5.62 ± 1.48

5.66 ± 1.14

0.886

0.695

0.403

K(min)

Pre-op

POD1

POD7

2.12 ± 0.77

2.11 ± 1.08

1.77 ± 0.47

2.39 ± 1.05

2.31 ± 1.27

1.60 ± 0.65

0.072

0.283

0.069

Alpha(°)

Pre-op

POD1

POD7

59.61 ± 6.36

63.03 ± 10.65

66.01 ± 7.31

59.05 ± 11.05

61.77 ± 10.73

66.80 ± 8.67

0.704

0.468

0.545

MA(mm)

Pre-op

POD1

POD7

60.08 ± 5.77

57.31 ± 7.46

64.10 ± 2.13

59.01 ± 5.67

58.37 ± 6.17

65.11 ± 7.88

0.254

0.341

0.286

CI

Pre-op

POD1

POD7

− 0.43 ± 1.54

− 0.48 ± 3.42

0.73 ± 0.63

− 0.66 ± 2.86

− 0.32 ± 2.70

0.90 ± 2.00

0.540

0.746

0.492

  1. *P < 0.05, Pre-op pre-operation, POD1 postoperative day 1, POD7 postoperative day 7, R reaction time, MA maximum amplitude, CI coagulation index